Polycyclic aromatic hydrocarbon compounds containing an S atom or S(═O)2 group in their basic structure
    5.
    发明授权
    Polycyclic aromatic hydrocarbon compounds containing an S atom or S(═O)2 group in their basic structure 有权
    在其基本结构中含有S原子或S(= O)2基团的多环芳烃化合物

    公开(公告)号:US09062207B2

    公开(公告)日:2015-06-23

    申请号:US13683622

    申请日:2012-11-21

    申请人: SICPA HOLDING SA

    IPC分类号: C09B57/08 C07D495/16 C09B5/62

    摘要: Polycyclic aromatic hydrocarbon compounds having an S atom or S(═O)2 moiety incorporated in their basic polycyclic structure that can have a nitrogen-containing heterocycloaliphatic group and/or a substituted or unsubstituted phenoxy group and/or a polymeric moiety bonded to the polycyclic structure and to compositions such as, e.g., printing inks which comprise these polycyclic aromatic hydrocarbons as colorants.

    摘要翻译: 具有S原子或S(= O)2部分的多环芳烃化合物掺入其碱性多环结构中,其可具有含氮杂环脂族基团和/或取代或未取代的苯氧基和/或与多环结合的聚合部分 结构和组合物,例如包含这些多环芳烃作为着色剂的印刷油墨。

    POLYCYCLIC AROMATIC HYDROCARBON COMPOUNDS CONTAINING AN S ATOM OR S(=O)2 GROUP IN THEIR BASIC STRUCTURE
    6.
    发明申请
    POLYCYCLIC AROMATIC HYDROCARBON COMPOUNDS CONTAINING AN S ATOM OR S(=O)2 GROUP IN THEIR BASIC STRUCTURE 有权
    包含其原子或S(= O)2组在其基本结构中的多环芳香烃化合物

    公开(公告)号:US20130127150A1

    公开(公告)日:2013-05-23

    申请号:US13683622

    申请日:2012-11-21

    申请人: Sicpa Holding SA

    IPC分类号: C09B57/08 C09B5/62

    摘要: Polycyclic aromatic hydrocarbon compounds having an S atom or S(═O)2 moiety incorporated in their basic polycyclic structure that can have a nitrogen-containing heterocycloaliphatic group and/or a substituted or unsubstituted phenoxy group and/or a polymeric moiety bonded to the polycyclic structure and to compositions such as, e.g., printing inks which comprise these polycyclic aromatic hydrocarbons as colorants.

    摘要翻译: 具有S原子或S(= O)2部分的多环芳族烃化合物掺入其碱性多环结构中,其可具有含氮杂环脂族基团和/或取代或未取代的苯氧基和/或与多环结合的聚合部分 结构和组合物,例如包含这些多环芳烃作为着色剂的印刷油墨。

    Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof
    9.
    发明申请
    Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof 审中-公开
    多环有机化合物,极化元素及其生产方法

    公开(公告)号:US20110149393A1

    公开(公告)日:2011-06-23

    申请号:US12921094

    申请日:2009-03-04

    摘要: This invention relates to polycyclic organic compounds of a general structural formula (I): wherein Y is a predominantly planar polycyclic system being at least partially aromatic, W1, W2, and W3 are different groups providing solubility in an organic solvent, and sum n1+n2+n3 is 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10, which are capable of forming supramolecular structures in a wide range of organic solvents, and which are capable of absorbing electromagnetic radiation in at least one subrange of the visible spectral range.

    摘要翻译: 本发明涉及一般结构式(I)的多环有机化合物:其中Y是至少部分为芳族的主要为平面的多环体系,W1,W2和W3是在有机溶剂中提供溶解度的不同基团,并且和n1 + n2 + n3是1,2,3,4,5,6,7,8,9或10,它们能够在宽范围的有机溶剂中形成超分子结构,并且能够至少吸收电磁辐射 一个可见光谱范围的子范围。

    PYRAZOLOPYRIMIDINE DERIVATIVE
    10.
    发明申请
    PYRAZOLOPYRIMIDINE DERIVATIVE 有权
    吡唑并嘧啶衍生物

    公开(公告)号:US20100113410A1

    公开(公告)日:2010-05-06

    申请号:US12442094

    申请日:2007-09-14

    摘要: Problem to be Solved To provide a novel compound inhibiting the effect of HSP90, in particular a novel compound inhibiting the function of HSP90 as a chaperone protein and having antitumor activity. Solution The present invention provides a pyrazolopyrimidine compound represented by the formula (1) having various substituents which inhibits the ATPase activity of HSP90 and which has antitumor activity, an HSP90 inhibitor comprising the compound represented by the formula (1), a medicament comprising the compound represented by the formula (1), an anticancer agent comprising the compound represented by the formula (1), a pharmaceutical composition comprising the compound represented by the formula (1) and a method for treating cancer using the compound represented by the formula (1).

    摘要翻译: 要解决的问题提供抑制HSP90的作用的新型化合物,特别是抑制HSP90作为伴侣蛋白的功能并具有抗肿瘤活性的新化合物。 溶液本发明提供了具有抑制HSP90的ATP酶活性且具有抗肿瘤活性的各种取代基的式(1)表示的吡唑并嘧啶化合物,包含由式(1)表示的化合物的HSP90抑制剂,包含化合物 (1)代表的抗癌剂,包含由式(1)表示的化合物的抗癌剂,包含式(1)表示的化合物的药物组合物和使用式(1)表示的化合物治疗癌症的方法 )。